{"DataElement":{"publicId":"6290029","version":"1","preferredName":"Liquid Enzalutamide Formulation Taste Description Type","preferredDefinition":"Text term that best describes the taste of the liquid enzalutamide formulation.","longName":"EZLTMD_LQ_TST_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6290193","version":"1","preferredName":"Liquid Dosage Form Enzalutamide Gustation Description","preferredDefinition":"A state of substance that is an intermediate one entered into as matter goes from solid to gas; liquids are also intermediate in that they have neither the orderliness of a crystal nor the randomness of a gas. (Note: This term should not be used to describe solutions, only pure chemicals in their liquid state.)_An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance._The faculty of taste, distinguishing substances by means of the taste buds._A written or verbal account, representation, statement, or explanation of something.","longName":"6289595v1.0:6289608v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6289595","version":"1","preferredName":"Liquid Dosage Form Enzalutamide","preferredDefinition":"A state of substance that is an intermediate one entered into as matter goes from solid to gas; liquids are also intermediate in that they have neither the orderliness of a crystal nor the randomness of a gas. (Note: This term should not be used to describe solutions, only pure chemicals in their liquid state.):An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.","longName":"C42953:C71744","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liquid Dosage Form","conceptCode":"C42953","definition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Enzalutamide","conceptCode":"C71744","definition":"An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C53345D-21C0-5FD8-E053-F662850AB836","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6289608","version":"1","preferredName":"Gustation Description","preferredDefinition":"The faculty of taste, distinguishing substances by means of the taste buds.:A written or verbal account, representation, statement, or explanation of something.","longName":"C20620:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gustation","conceptCode":"C20620","definition":"The faculty of taste, distinguishing substances by means of the taste buds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C53476D-4906-5FDC-E053-F662850A62B9","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C5792EF-68F7-0AE2-E053-F662850A9055","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeDescription":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6289999","version":"1","preferredName":"Taste Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"TASTE_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C570E48-03A8-0963-E053-F662850A62AB","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","deletedIndicator":"No"},{"value":"bitter","valueDescription":"Bitter","ValueMeaning":{"publicId":"6290000","version":"1","preferredName":"Bitter","longName":"6290000","preferredDefinition":"Having a sharp, pungent taste.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bitter","conceptCode":"C150481","definition":"Having a sharp, pungent taste.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C570E48-03B2-0963-E053-F662850A62AB","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C570E48-03CB-0963-E053-F662850A62AB","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","deletedIndicator":"No"},{"value":"salty","valueDescription":"Salty","ValueMeaning":{"publicId":"6290001","version":"1","preferredName":"Salty","longName":"6290001","preferredDefinition":"Tasting of or like salt.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salty","conceptCode":"C150480","definition":"Tasting of or like salt.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C570E48-03D5-0963-E053-F662850A62AB","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C570E48-03EE-0963-E053-F662850A62AB","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","deletedIndicator":"No"},{"value":"sweet","valueDescription":"Sweet","ValueMeaning":{"publicId":"6290002","version":"1","preferredName":"Sweet","longName":"6290002","preferredDefinition":"Having or resembling the taste of sugar.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sweet","conceptCode":"C62182","definition":"Having or resembling the taste of sugar.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C570E48-03FA-0963-E053-F662850A62AB","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C570E48-0413-0963-E053-F662850A62AB","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"ONEDATA","dateModified":"2018-05-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C570E48-0392-0963-E053-F662850A62AB","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeDescription":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which of the following best d","type":"Preferred Question Text","description":"Which of the following best describes the taste of the liquid enzalutamide formulation?","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C570EAC-F623-0AF2-E053-F662850AC73E","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeDescription":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}